1. Devarajan P. Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology: JASN. 2006; 17: 1503-1520. doi: 10.1681/ASN.2006010017
2. Tsuda H, Yamahara K, Otani K, et al. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protect against ischemia-reperfusion-induced acute kidney injury. Cell transplantation. 2014. doi: 10.3727/096368913X665594
3. Villanueva S, Carreno JE, Salazar L, et al. Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure. Clin Sci (Lond). 2013; 125: 199-210. doi: 10.1042/CS20120644
4. Erpicum P, Detry O, Weekers L, et al. Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2014. doi: 10.1093/ndt/gft538
5. Forostyak S, Jendelova P, Sykova E. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie. 2013; 95: 2257-2270. doi: 10.1016/j.biochi.2013.08.004
6. Gatti S, Bruno S, Deregibus MC, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2011; 26: 1474-1483. doi: 10.1093/ndt/gfr015
7. Zou X, Zhang G, Cheng Z, et al. Microvesicles derived from human Wharton’s Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1. Stem cell research & therapy. 2014; 5: 40. doi: 10.1186/scrt428
8. Grange C, Tapparo M, Bruno S, et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. International journal of molecular medicine. 2014; 33: 1055-1063. doi: 10.3892/ijmm.2014.1663
9. Cao H1, Qian H, Xu W, et al. Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia reperfusion-induced acute renal failure in rats. Biotechnol Lett. 20010; 32(5): 725-732. doi: 10.1007/s10529-010-0207-y
10. Liu YL, Wanga YD, Zhuanga F, Xian SL. Immunosuppression effects of bone marrow mesenchymal stem cells on renalinterstitial injury in rats with unilateral ureteral obstruction. Cell Immunol. 2012; 276(1-2):144-52. doi: 10.1016/j.cellimm.2012.05.001
11. Semedo P, Palasio CG, Oliveira CD, et al. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. International immunopharmacology. 2009; 9: 677-682. doi: 10.1016/j.intimp.2008.12.008
12. Hu J, Zhang L, Wang N, et al. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney international. 2013; 84: 521-531. doi: 10.1038/ki.2013.114
13. Patschan D, Patschan S, Muller GA. Inflammation and microvasculopathy in renal ischemia reperfusion injury. Journal of transplantation. 2012; 764154. doi: 10.1155/2012/764154
14. Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. Journal of the American Society of Nephrology: JASN. 2011; 22: 317-326. doi: 10.1681/ASN.2009060615
15. Ascon DB, Lopez-Briones S, Liu M, et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. Journal of immunology. 2006; 177: 3380-3387. doi: 10.4049/jimmunol.177.5.3380
16. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney international. 2010; 77: 771-780. doi: 10.1038/ki.2010.12
17. Li L, Huang L, Sung SsJ, et al. NKT cell activation mediates neutrophil IFN- production and renal ischemia-reperfusion injury. The Journal of Immunology. 2007; 178: 5899-5911. doi: 10.4049/jimmunol.178.9.5899
18. Vinuesa E, Hotter G, Jung M, Herrero-Fresneda I, Torras J, Sola A. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. The Journal of pathology. 2008; 214: 104-113. doi: 10.1002/path.2259
19. Millar TM, Phan V, Tibbles LA. ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment. Free radical biology & medicine. 2007; 42: 1165-1177. doi: 10.1016/j.freeradbiomed.2007.01.015
20. Zhang ZX, Wang S, Huang X, et al. NK Cells Induce Apoptosis in Tubular Epithelial Cells and Contribute to Renal Ischemia-Reperfusion Injury. The Journal of Immunology. 2008; 181: 7489-7498. doi: 10.4049/jimmunol.181.11.7489
21. Jung M, Sola A, Hughes J, et al. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2. Kidney international. 2012; 81: 969-982. doi: 10.1038/ki.2011.446
22. Lu L, Faubel S, He Z, et al. Depletion of macrophages and dendritic cells in ischemic acute kidney injury. American journal of nephrology. 2012; 35: 181-190. doi: 10.1159/000335582
23. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005; 105: 2821-2827. doi: 10.1182/blood-2004-09-3696
24. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006; 107: 1484-1490. doi: 10.1182/blood-2005-07-2775
25. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American journal of physiology, Renal physiology.2005; 289: F31-F42. doi: 10.1152/ajprenal.00007.2005
26. Eliopoulos N, Zhao J, Bouchentouf M, et al. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice postintraperitoneal injection. American journal of physiology, Renal physiology. 2010; 299: F1288-F1298. doi: 10.1152/ajprenal.00671.2009
27. Tsuda H, Yamahara K, Otani K, et al. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury. Cell transplantation. 2014; 23: 889-899. doi: 10.3727/096368913X665594
28. Luo CJ, Zhang FJ, Zhang L, et al. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock. 2014; 41: 123-129. doi: 10.1097/SHK.0000000000000080
29. Zhu YG, Feng XM, Abbott J, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells. 2014; 32: 116-125. doi: 10.1002/stem.1504
30. Kim MG, Lee SY, Ko YS, et al. CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2011; 26: 111-124. doi: 10.1093/ndt/gfq480
31. Burne-Taney MJ, Liu M, Baldwin WM, Racusen L, Rabb H. Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. Journal of immunology. 2006; 176: 7015-7020. doi: 10.4049/jimmunol.176.11.7015
32. Alikhan MA, Ricardo SD. Mononuclear phagocyte system in kidney disease and repair. Nephrology 2012. doi: 10.1111/nep.12014
33. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. Journal of the American Society of Nephrology: JASN. 2000; 11: 152-176. doi: 10.1681/asn.v111152
34. Ho AW, Wong CK, Lam CW. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Immunobiology. 2008; 213: 533-544. doi: 10.1016/j.imbio.2008.01.003
35. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation research. 2010; 107: 1047-1057. doi: 10.1161/circresaha.110.226456
36. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Current opinion in hematology. 2004; 11: 156-164. doi: 10.1097/01.moh.0000131441.10020.87
37. Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007; 110: 2440-2448. doi: 10.1182/blood-2007-03-078709
38. Bruno S, Grange C, Deregibus MC, et al. Mesenchymal stem cell-derived micro vesicles protect against acute tubular injury. Journal of the American Society of Nephrology: JASN. 2009; 20: 1053-1067. doi: 10.1681/ASN.2008070798
39. Lindoso RS, Collino F, Bruno S, et al. Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury. Stem cells and development. 2014. doi: 10.1089/scd.2013.0618
40. Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. Journal of molecular medicine. 2014; 92: 387-397. doi: 10.1007/s00109-013-1110-5
41. Li W, Zhang Q, Wang M, et al. Macrophages are involved in the protective role of human umbilical cord-derived stromal cells in renal ischemia-reperfusion injury. Stem cell research. 2013; 10: 405-416. doi: 10.1016/j.scr.2013.01.005
42. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20: 1487-1495. doi: 10.1038/sj.leu.2404296
43. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends in cell biology. 2009; 19: 43-51. doi: 10.1016/j.tcb.2008.11.003